The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2020

Filed:

Dec. 17, 2014
Applicant:

Cardiovascular Biotherapeutics, Inc., Las Vegas, NV (US);

Inventors:

Vance Gardner, Irvine, CA (US);

Hon Yu, Irvine, CA (US);

Kenneth A. Thomas, Chatham, NJ (US);

Thomas J. Stegmann, Petersberg, DE;

John W. Jacobs, Berkeley, CA (US);

Tugan Muftuler, Aliso Viejo, CA (US);

Shadfar Bahri, Irvine, CA (US);

Assignees:

CardioVascular BioTherapeutics, Inc., Las Vegas, NV (US);

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/20 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); G01N 33/84 (2006.01); G01N 33/74 (2006.01); A61K 38/19 (2006.01); A61K 38/22 (2006.01);
U.S. Cl.
CPC ...
A61K 38/204 (2013.01); A61K 38/1709 (2013.01); A61K 38/18 (2013.01); A61K 38/185 (2013.01); A61K 38/1808 (2013.01); A61K 38/1825 (2013.01); A61K 38/1833 (2013.01); A61K 38/1858 (2013.01); A61K 38/1866 (2013.01); A61K 38/1875 (2013.01); A61K 38/1891 (2013.01); A61K 38/19 (2013.01); A61K 38/193 (2013.01); A61K 38/2006 (2013.01); A61K 38/22 (2013.01); G01N 33/74 (2013.01); G01N 33/84 (2013.01); G01N 2333/50 (2013.01); G01N 2333/96486 (2013.01); G01N 2800/10 (2013.01); G01N 2800/105 (2013.01);
Abstract

The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.


Find Patent Forward Citations

Loading…